Also Known As:
SMA (Spinal Muscular Atrophy) Carrier detection study by MLPA
Carrier screening for Spinal Muscular Atrophy (SMA) using MLPA (Multiplex Ligation-dependent Probe Amplification) is a genetic test that identifies individuals carrying a mutated copy of the SMN1 gene - the primary cause of SMA, a rare genetic disorder that affects the motor neurons in the spinal cord.
Includes 1 Test Parameters
Test Preparation:
No Special Preparation. Informed Consent Required.
Reporting TAT:
24 Hours